openPR Logo
Press release

Synthetic Human Tissues E-Commerce Site

10-20-2008 03:23 PM CET | Health & Medicine

Press release from: Animal Replacement Technologies

Synthetic Human Aortic Arch

Synthetic Human Aortic Arch

Animal Replacement Technologies announced today the launch of their E-commerce site (store.anireptec.com) for North America and Europe. A full range of synthetic human tissues and body parts are now available for purchase on the site via, credit card, check, or purchase order.

Animal Replacement Technologies, based in Florida, USA, develops sophisticated synthetic human tissues and body parts for the medical device, consumer product, and military technology industries. This technology employs replacable muscles, tendons, veins, arteries, and organs; all made from novel materials that mimic the structural, chemical, and mechanical properties of discrete living tissues. Our products are currently used by Fortune 500 medical device manufacturers in validation testing, by medical professionals in surgical training, and by military manufacturers in ballistics testing.

Medical product designers, researchers, and educators also use Animal Replacement Technologies' products to perform highly compelling comparative benchmarking studies. Such tests allow the developer to illustrate performance differences between prototype variants or prototypes and previously released devices. Used in this capacity, our modeling technology is the best tool available for supporting substantial equivalence claims to the FDA.

"There is no rubber, glass, or plastic in our products", says Dr. Christopher Sakezles, the President of Animal Replacement Technologies. "Our synthetic human tissues are designed on the basis of tests performed on live tissues, and much like the real thing these analog materials are composed primarily of water, fibers, and salts. In fact, each component we make, such as an synthetic human aorta, is itself comprised of multiple complex constructions . . . these are highly sophisticated products made from very complex composite materials."

Dr. Christopher Sakezles
President, Chief Technology Officer
Animal Replacement Technologies
11523 Palmbrush Trail, Suite 106
Bradenton, Florida 34202
Main: 941-727-0488
Fax: 941-870-3461

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Synthetic Human Tissues E-Commerce Site here

News-ID: 57105 • Views:

More Releases from Animal Replacement Technologies

Animal Replacement Technologies - Convertible Bond Offering
Animal Replacement Technologies - Convertible Bond Offering
Animal Replacement Technologies announced today the availability of $1 million USD in convertible bonds in conjunction with their IPO (Initial Private Offering). These securities will pay 15% annually in quarterly installments and may be exchanged for common stock either upon demand or at the company\'s first organized equity offering (scheduled for late 2008). This opportunity is open to individuals, business entities, and educational institutions, and will involve up to $1
Animal Replacement Technologies - Stock Offering
Animal Replacement Technologies - Stock Offering
Animal Replacement Technologies announced today the opening of a new (Series A) private stock offering to fund initial expansion. This opportunity is open to individuals, business entities, and educational institutions, and will involve the placement of up to 1 million shares of common stock at $1 USD per share. A complete prospectus is available for review by potential investors. Animal Replacement Technologies is a high-tech startup company based in Sarasota, Florida
Second Generation Vascular Lesion Models
Second Generation Vascular Lesion Models
Animal Replacement Technologies announced today the launch of their second-generation arterial lesions. These lesions are more sophisticated that the original chronic total occlusion models, and are designed to integrate with the company\'s current peripheral, coronary, and cerebral vascular products. these may be mounted in straight or branched sections as small as 1mm in diameter, may be softcap or hardcap, chronic total occlusions or characterized by a particular TIMI flow, and
Animal Replacement Technologies - Chief Operating Officer Search
Animal Replacement Technologies - Chief Operating Officer Search
Animal Replacement Technologies announced today the opening of a search for the position of Chief Operating Officer. This new position shall report directly to the President, and will carry executive responsibility for fundraising, sales and marketing, and general business administration. The individual ideally suited for this position will have an MBA from a reputable university and executive-level experience in the medical device, pharmaceutical, or biotechnology industries. Animal Replacement Technologies, based in

All 5 Releases


More Releases for Synthetic

Synthetic Diamond Market Report 2024 - Synthetic Diamond Market Trends, Drivers …
"The Business Research Company recently released a comprehensive report on the Global Synthetic Diamond Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Synthetic Biology Market - Engineering life's possibilities: Synthetic biology s …
Newark, New Castle, USA: The "Synthetic Biology Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Synthetic Biology Market: https://www.growthplusreports.com/report/synthetic-biology-market/7970 This latest report researches the industry structure, sales, revenue,
Global Synthetic Dye and Pigment Market, Global Synthetic Dye and Pigment Indust …
The synthetic dyes and pigments market entails of the sales of synthetic dyes and pigments by several entities (organizations, sole traders or partnerships) that manufacture synthetic organic and inorganic dyes and pigments, such as lakes and toners (excluding electrostatic and photographic). Pigments that are gained from natural minerals as well as synthetic pigments are comprised in this market. Artificial food-coloring is also comprised in this market. Synthetic dyes and pigments
Synthetic Camphor Market
Research Dive has added a new report on the global synthetic camphor market to its repository. According to the report, the global synthetic camphor market is anticipated to hit $448.1 million by rising at a CAGR of 5.9% from 2019 to 2027. This report highlights various the important factors of the market such as key market segments, market dynamics & statistics, boomers, restraints, market players, and investment opportunities. It is
Synthetic Spider Silk Market
Market Overview: Synthetic spider silk is an alternative to the conventional spider silk replicating the latter’s features such as energy-absorbent nature, elasticity and strength. Water content in synthetic spider silk amounts up to 98%. Synthetic spider silk is made from hydrogel, which comprises of 98% of water and 2% of silica and cellulose. Synthetic spider silk is weaker compared to its natural counterpart, however, they are far stronger compared to other
Synthetic Biology Market – Europe
Synthetic Biology Market Europe is expected to reach USD XX Billion by 2026 from USD XX Billion in 2016 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). Synthetic biology has expanded into various interdisciplinary fields that may be defined as the combination of artificial design and engineering to produce biological systems, chemicals or living organisms. Synthetic biology is also used for improving applications